India's Dr Reddy's Q2 net up 177 pct
BANGALORE |
BANGALORE Oct 23 (Reuters) - Indian drug maker Dr Reddy's Laboratories Ltd (REDY.BO) said on Friday its consolidated quarterly profit rose 176.8 percent, helped by the launch of new generics in the overseas market.
The New York-listed company (RDY.N) reported a net profit of 2.4 billion rupees ($51.7 million) in July-September, its fiscal second quarter, compared with 866.4 million rupees in the year-ago period.
Net sales rose to 18.1 billion rupees from 15.76 billion year-ago.
($1=46.4 rupees) (Reporting by Janaki Krishnan; Editing by Jarshad Kakkrakandy)
- Tweet this
- Link this
- Share this
- Digg this
- Reprints
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.
Follow Reuters